Mauro Krampera
- Genetics top 0.02%
- Mesenchymal stem cell research 53
- Chronic Lymphocytic Leukemia Research 17
- Developmental Neuroscience top 0.5%
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 15
- Rehabilitation top 0.5%
- Immunology top 1%
- Immune Cell Function and Interaction 17
-
- Cancer Cells and Metastasis 20
-
- Tissue Engineering and Regenerative Medicine 18
-
- Lymphoma Diagnosis and Treatment 17
-
- Acute Lymphoblastic Leukemia research 16
- Co-authors
- Giovanni PizzoloAnnalisa PasiniFrancesco DazziLuc SensebéElizabeth SimpsonSarah J. GlennieDiane ScottJulian Dyson
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Mauro Krampera
154 papers receiving 10.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Genetics 6.7k
- Developmental Neuroscience 552
- Hematology 1.2k
- Rehabilitation 708
- Immunology 1.9k
Countries citing papers authored by Mauro Krampera
This map shows the geographic impact of Mauro Krampera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Krampera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Krampera more than expected).
Fields of papers citing papers by Mauro Krampera
This network shows the impact of papers produced by Mauro Krampera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Krampera. The network helps show where Mauro Krampera may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mauro Krampera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cellsbreakdown → | 2025 | 17 |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 40 | |
| 10 | 2020 | 29 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 15 | |
| 13 | 2019 | 23 | |
| 14 | 2018 | 31 | |
| 15 | 2014 | 15 | |
| 16 | 2014 | 35 | |
| 17 | 2013 | 154 | |
| 18 | 2010 | 15 | |
| 19 | 2008 | 186 | |
| 20 | 2007 | 98 |
About Mauro Krampera
Mauro Krampera is a scholar working on Genetics, Hematology and Oncology, having authored 160 papers that have together received 11.1k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (53 papers), Cancer Cells and Metastasis (20 papers), Tissue Engineering and Regenerative Medicine (18 papers), Chronic Lymphocytic Leukemia Research (17 papers), Immune Cell Function and Interaction (17 papers), Lymphoma Diagnosis and Treatment (17 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (15 papers). The work is most often cited by research in Genetics (6.7k citations), Developmental Neuroscience (552 citations) and Hematology (1.2k citations). Mauro Krampera has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Giovanni Pizzolo, Annalisa Pasini, Francesco Dazzi, Luc Sensebé, Elizabeth Simpson, Sarah J. Glennie, Diane Scott, Julian Dyson, R. Laylor and Andrea Sbarbati. Their work appears in journals such as Blood, Cytotherapy, Stem Cells and Development, Stem Cells and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.